Sarissa Capital

Sarissa Capital Management operates as an activist hedge fund primarily focused on the healthcare and biotechnology sectors. The firm employs constructive shareholder activism, engaging directly with portfolio companies to enhance governance, improve operational efficiencies, and unlock intrinsic value. Its strategy combines deep fundamental analysis with strategic board representation to optimize performance and maximize returns.

Dr. Alexander John Denner, Chief Investment Officer, founded Sarissa Capital in 2012. He leveraged significant experience as a senior investment professional at Icahn Capital LP under Carl C. Icahn. Denner's core insight was applying a hands-on ownership model within healthcare, targeting companies where strategic intervention improves focus and valuation.

Sarissa Capital primarily serves institutional investors via its pooled investment vehicles. The firm envisions transforming underperforming healthcare and biotech companies through robust governance and precise strategic direction. It aims to create substantial value by shaping corporate outcomes, ensuring management accountability, and fostering sustained growth toward market leadership.